Exagen Inc.
A patient focused, discovery driven life science company.
Vista, United States
200 employees
Post-IPO Debt
Total: $178.39M
Biotechnology, Health Care +2
General Information
Vista, United States
BounceWatch is an independent company data service, not affiliated with Exagen Inc.. To contact Exagen Inc., visit exagen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Exagen Inc. compare?
A PDF of Exagen Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Exagen Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Exagen Inc.
Funding Rounds & Investors (15)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Debt | $27.20M | 1 |
|
25 Oct 2021 |
| Debt Financing | $25.00M | 1 |
|
10 Oct 2017 |
| Debt Financing | $2.10M | - |
|
24 Jun 2016 |
| Series E | $16.80M | - |
|
26 Jan 2016 |
| Debt Financing | $3.00M | - |
|
06 Jul 2015 |
| Debt Financing | $3.95M | 4 |
|
21 Jul 2014 |
| Debt Financing | $25.00M | 6 |
|
04 Nov 2013 |
| Series D | $5.00M | 1 |
|
01 Oct 2013 |
| Venture Round | $34.10M | 3 |
|
16 Feb 2012 |
| Debt Financing | $1.00M | - |
|
04 Nov 2011 |
Exagen Inc. Alternatives & Competitors
View All Alternatives
AI‑Driven Clinical Insights for Genomic Data
Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions
The Pacific Northwest's premier laboratory, recognized for diagnostic excellence, professionalism an...
FAQ About Exagen Inc.
Source: BounceWatch company record for Exagen Inc., https://bouncewatch.com/company/exagen, updated 29 December 2024. When citing, please name BounceWatch and link this page.
